Business
Cadiz owns water, land, pipeline and filtration assets intended to supply communities in the U.S. Southwest.
Cadiz accelerated water-project revenue, but losses and cash burn remained far larger than sales as the company continued funding long-duration infrastructure development.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 69.8%OK
- Profitability — The net loss widened from $31.14M to $34.151MWatch
- Cash flow — Free cash flow remained negative, with the outflow widening from $22.466M to $26.506MWatch
- Margins — Operating margin expanded 8506 bps to -156.92%OK
- Accounting — Water-asset growth with heavy development fundingWatch
- Insiders — 1 purchases and 1 salesOK
Where the revenue comes from
Fiscal 2025, as CADIZ INC reports it. History and quarterly detail are in the app.
- Water Treatment$14.5M
- Water and Land Resources$1.8M
Leadership changes
From CADIZ INC's own filings, the day they're filed.
- Dave O'Hara · Directors · appointmenteff. 2026-02-03
- Cathryn R. Rivera · Chief Operating Officer · appointmenteff. 2024-09-16
- Employment Term · Chief Operating Officer · departureeff. 2024-09-16
Latest filings
- 10-Q · Quarterly report2026-08-13
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-27
- 8-K · Company announcement2026-07-15
- 8-K · Company announcement2026-06-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CADIZ INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.